Newsfeeds - Spark Newswire

1 minute read

News

MannKind Files For U.S. Patent Application Titled ‘HEAT-STABLE DRY POWDER PHARMACEUTICAL COMPOSITIONS AND METHODS’

Today, 12:58 PM

https://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.html&r=6456&p=130&f=G&l=50&d=PG01&S1=20210812.PD.&OS=PD/20210812&RS=PD/20210812

MNKD

5 minute read

The Daily Biotech Pulse: FDA Rejects FibroGen’s Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering

By Shanthi Rexaline

Today, 12:58 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10)

ACAD

11 minute read

Earnings Scheduled For August 11, 2021

By Benzinga Insights

Today, 12:58 PM

Companies Reporting Before The Bell • Wireless Telecom Group (AMEX:WTT) is likely to report earnings for its second quarter.

ACVA

2 minute read

MannKind’s Debt Overview

By Benzinga Insights

Today, 12:58 PM

Shares of MannKind (NASDAQ:MNKD) moved higher by 1.74% in the past three months. Before having a look at the importance of debt, let us look at how much debt MannKind has.

MNKD

7 minute read

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight

By Shanthi Rexaline

Today, 12:58 PM

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.

ABCL

6 minute read

The Daily Biotech Pulse: Pfizer’s Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings

By Shanthi Rexaline

Today, 12:58 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3)

ABSI

2 minute read

MannKind Corporation And NRx Pharmaceuticals To Evaluate Feasibility Of Formulating A Dry Powder Formulation Of ZYESAMI

By Bill Haddad

Today, 12:58 PM

MannKind Corporation (NASDAQ:MNKD) has partnered with NRx Pharmaceuticals (NASDAQ:NRXP) (NRx) to evaluate the feasibility of formulating a dry powder formulation of ZYESAMI™ (aviptadil), a synthetic

MNKD

2 minute read

3 Penny Stocks Insiders Are Buying

By Lisa Levin

Today, 12:58 PM

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

EMMA

1 minute read

Legal
News

MannKind Corporation Granted U.S. Patent Titled ‘Apparatus and method for cryogranulating a pharmaceutical composition’

By Benzinga Newsdesk

Today, 12:58 PM

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=6723&f=G&l=50&d=PTXT&p=135&S1=20210803&OS=20210803&RS=20210803

MNKD